Australia-based healthcare and pharmaceutical group, Stirling Products has acquired a pharmaceutical manufacturing facility in Cape Breton, Nova Scotia. Stirling will use the facility for a number of third party contract generics manufacturing opportunities, funded research opportunities and pharmaceutical product production. The facility has been established as a pharmaceutical production complex and is fitted out with extensive laboratory and drug manufacturing and packaging plant. The facility features a fully fitted out laboratory, water filtration systems, auto mixing units ranging to 3,000 kg capacity and two fully automated filling, labelling and packaging lines.
Read more : Australia’s Stirling Products establishes presence in Nova Scotia